⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

Official Title: PRIMUS 001: An Adaptive Phase II Study of FOLFOX-A (FOLFOX and Nab-paclitaxel) Versus AG (Nab-paclitaxel and Gemcitabine) in Patients With Metastatic Pancreatic Cancer, With Integrated Biomarker Evaluation

Study ID: NCT04151277

Study Description

Brief Summary: This study is comparing two combinations of chemotherapy treatments in patients with metastatic pancreatic cancer. Half the participants will receive FOLFOX-A and the other half will receive AG. Treatment will continue until progression or patient/clinican decision or intolerable toxicity.

Detailed Description: PRIMUS 001 is a multicentre, randomised, open label, two arm, phase II interventional trial with pre-clinical and translational work including in-depth molecular profiling and biomarker discovery/development. The primary objective is to look at the efficacy of FOLFOX-A compared to AG in all comers and in a biomarker positive group using progression free survival.

Keywords

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Aberdeen Royal Infirmary, Aberdeen, , United Kingdom

Northern Ireland Cancer Centre, Belfast, , United Kingdom

Queen Elizabeth Hospital, Birmingham, , United Kingdom

Royal Bournemouth Hospital, Bournemouth, , United Kingdom

Bristol Oncology Centre, Bristol, , United Kingdom

Addenbrooke's Hospital, Cambridge, , United Kingdom

Castle Hill Hospital, Cottingham, , United Kingdom

Ninewells Hospital, Dundee, , United Kingdom

Western General, Edinburgh, , United Kingdom

Beatson West of Scotland Cancer Centre, Glasgow, , United Kingdom

Huddersfield Royal Infirmary, Huddersfield, , United Kingdom

Raigmore Hospital, Inverness, , United Kingdom

St James's University Hospital, Leeds, , United Kingdom

The Clatterbridge Cancer Centre, Liverpool, , United Kingdom

Guy's Hospital, London, , United Kingdom

Imperial College Healthcare Trust, London, , United Kingdom

Royal Free London Hospital, London, , United Kingdom

Royal Marsden Hospital, London, , United Kingdom

St Bart's Hospital, London, , United Kingdom

St George's Hospital, London, , United Kingdom

University College London Hospital, London, , United Kingdom

The Christie, Manchester, Manchester, , United Kingdom

Milton Keynes General Hospital, Milton Keynes, , United Kingdom

Freeman Hospital, Newcastle, , United Kingdom

Nottingham University Hospital, Nottingham, , United Kingdom

Churchill Hospital, Oxford, , United Kingdom

Poole Hospital, Poole, , United Kingdom

Weston Park, Sheffield, , United Kingdom

University of Southampton Hospital, Southampton, , United Kingdom

Singleton Hospital, Swansea, , United Kingdom

Contact Details

Name: Janet Graham

Affiliation: NHS Greater Glasgow and Clyde

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: